We are live on ! Find out more
IONS icon

Ionis Pharmaceuticals
IONS

173 hedge funds and large institutions have $2.84B invested in Ionis Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 173 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more call options, than puts

Call options by funds: $36M | Put options by funds: $29.5M

Holders
173
Holders Change
+173
Holders Change %
–
% of All Funds
5.65%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.1%
New
173
Increased
–
Reduced
–
Closed
–
Calls
$36M
Puts
$29.5M
Net Calls
+$6.51M
Net Calls Change
+$6.51M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
NSEDCP
126
NJ State Employees Deferred Compensation Plan
New Jersey
$537K +$425K +20,000 New
SFSIG
127
San Francisco Sentry Investment Group
California
$537K +$425K +20,000 New
PI
128
Placemark Investments
Illinois
$505K +$399K +18,785 New
PNC Financial Services Group
129
PNC Financial Services Group
Pennsylvania
$505K +$400K +18,826 New
DADC
130
D.A. Davidson & Co
Montana
$488K +$387K +18,192 New
HK
131
Horizon Kinetics
New York
$457K +$362K +17,000 New
OAM
132
Orinda Asset Management
California
$424K +$336K +15,781 New
Federated Hermes
133
Federated Hermes
Pennsylvania
$424K +$336K +15,788 New
PCM
134
Prelude Capital Management
New York
$403K +$319K +15,000 New
ACM
135
Advent Capital Management
New York
$390K +$308K +14,500 New
ST
136
Spot Trading
Illinois
$354K +$280K +13,187 New
GA
137
Gateway Advisory
New Jersey
$336K +$266K +12,500 New
CAM
138
Capstone Asset Management
Texas
$325K +$257K +12,077 New
QIM
139
Quest Investment Management
Oregon
$324K +$257K +12,075 New
Two Sigma Advisers
140
Two Sigma Advisers
New York
$290K +$229K +10,790 New
WAM
141
World Asset Management
Michigan
$279K +$220K +10,365 New
AC
142
Alexandria Capital
Virginia
$269K +$213K +10,000 New
SB
143
Suntrust Banks
Georgia
$259K +$206K +9,664 New
Ameriprise
144
Ameriprise
Minnesota
$222K +$176K +8,274 New
Teacher Retirement System of Texas
145
Teacher Retirement System of Texas
Texas
$204K +$162K +7,606 New
Citadel Advisors
146
Citadel Advisors
Florida
$202K +$160K +7,515 New
CEP
147
Chicago Equity Partners
Illinois
$202K +$161K +7,550 New
RFS
148
Rockefeller Financial Services
New York
$164K +$130K +6,104 New
LTFS
149
Ladenburg Thalmann Financial Services
Florida
$155K +$122K +5,746 New
ILIM
150
Irish Life Investment Managers
Ireland
$108K +$85.6K +4,024 New
3 4 5
6
7

IONS Hedge Fund Activity: Q2 2013 in Review

173 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Ionis Pharmaceuticals (IONS) for Q2 2013, worth a combined $2.84B.

Buyers outnumbered sellers: 173 funds opened new IONS positions and 0 closed out — a net gain of 173 holders — while 0 added to existing stakes and 0 trimmed.

  • 173 institutional investors held Ionis Pharmaceuticals (IONS) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $2.84B of Ionis Pharmaceuticals stock for Q2 2013.
  • 173 funds opened new Ionis Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +173 holders.

Based on aggregated 13F filings for Q2 2013.